Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998733860> ?p ?o ?g. }
- W1998733860 endingPage "1769" @default.
- W1998733860 startingPage "1761" @default.
- W1998733860 abstract "Objectives: To compare outcomes of antiretroviral therapy (ART) in South Africa, where viral load monitoring is routine, with those in Malawi and Zambia, where monitoring is based on CD4 cell counts. Methods: We included 18 706 adult patients starting ART in South Africa and 80 937 patients in Zambia or Malawi. We examined CD4 responses in models for repeated measures and the probability of switching to second-line regimens, mortality and loss to follow-up in multistate models, measuring time from 6 months. Results: In South Africa, 9.8% [95% confidence interval (CI) 9.1–10.5] had switched at 3 years, 1.3% (95% CI 0.9–1.6) remained on failing first-line regimens, 9.2% (95% CI 8.5–9.8) were lost to follow-up and 4.3% (95% CI 3.9–4.8) had died. In Malawi and Zambia, more patients were on a failing first-line regimen [3.7% (95% CI 3.6–3.9], fewer patients had switched [2.1% (95% CI 2.0–2.3)] and more patients were lost to follow-up [15.3% (95% CI 15.0–15.6)] or had died [6.3% (95% CI 6.0–6.5)]. Median CD4 cell counts were lower in South Africa at the start of ART (93 vs. 132 cells/μl; P < 0.001) but higher after 3 years (425 vs. 383 cells/μl; P < 0.001). The hazard ratio comparing South Africa with Malawi and Zambia after adjusting for age, sex, first-line regimen and CD4 cell count was 0.58 (0.50–0.66) for death and 0.53 (0.48–0.58) for loss to follow-up. Conclusion: Over 3 years of ART mortality was lower in South Africa than in Malawi or Zambia. The more favourable outcome in South Africa might be explained by viral load monitoring leading to earlier detection of treatment failure, adherence counselling and timelier switching to second-line ART." @default.
- W1998733860 created "2016-06-24" @default.
- W1998733860 creator A5010315274 @default.
- W1998733860 creator A5011657274 @default.
- W1998733860 creator A5015458167 @default.
- W1998733860 creator A5030664010 @default.
- W1998733860 creator A5032374309 @default.
- W1998733860 creator A5048848299 @default.
- W1998733860 creator A5051693361 @default.
- W1998733860 creator A5052633473 @default.
- W1998733860 creator A5056779273 @default.
- W1998733860 creator A5074213191 @default.
- W1998733860 creator A5077161809 @default.
- W1998733860 creator A5079043712 @default.
- W1998733860 date "2011-09-10" @default.
- W1998733860 modified "2023-10-16" @default.
- W1998733860 title "Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa" @default.
- W1998733860 cites W1577924091 @default.
- W1998733860 cites W1600314899 @default.
- W1998733860 cites W1767940945 @default.
- W1998733860 cites W1963726179 @default.
- W1998733860 cites W2001017566 @default.
- W1998733860 cites W2016010619 @default.
- W1998733860 cites W2020672863 @default.
- W1998733860 cites W2022704364 @default.
- W1998733860 cites W2031368727 @default.
- W1998733860 cites W2035309145 @default.
- W1998733860 cites W2044978549 @default.
- W1998733860 cites W2045871034 @default.
- W1998733860 cites W2057847137 @default.
- W1998733860 cites W2059780880 @default.
- W1998733860 cites W2078262030 @default.
- W1998733860 cites W2081385389 @default.
- W1998733860 cites W2084921375 @default.
- W1998733860 cites W2115830594 @default.
- W1998733860 cites W2139265966 @default.
- W1998733860 cites W2142665794 @default.
- W1998733860 cites W2150464933 @default.
- W1998733860 cites W2155999101 @default.
- W1998733860 cites W2156440755 @default.
- W1998733860 cites W2163477848 @default.
- W1998733860 cites W2168405519 @default.
- W1998733860 cites W86391216 @default.
- W1998733860 doi "https://doi.org/10.1097/qad.0b013e328349822f" @default.
- W1998733860 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3605707" @default.
- W1998733860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21681057" @default.
- W1998733860 hasPublicationYear "2011" @default.
- W1998733860 type Work @default.
- W1998733860 sameAs 1998733860 @default.
- W1998733860 citedByCount "102" @default.
- W1998733860 countsByYear W19987338602012 @default.
- W1998733860 countsByYear W19987338602013 @default.
- W1998733860 countsByYear W19987338602014 @default.
- W1998733860 countsByYear W19987338602015 @default.
- W1998733860 countsByYear W19987338602016 @default.
- W1998733860 countsByYear W19987338602017 @default.
- W1998733860 countsByYear W19987338602018 @default.
- W1998733860 countsByYear W19987338602019 @default.
- W1998733860 countsByYear W19987338602020 @default.
- W1998733860 countsByYear W19987338602021 @default.
- W1998733860 countsByYear W19987338602022 @default.
- W1998733860 countsByYear W19987338602023 @default.
- W1998733860 crossrefType "journal-article" @default.
- W1998733860 hasAuthorship W1998733860A5010315274 @default.
- W1998733860 hasAuthorship W1998733860A5011657274 @default.
- W1998733860 hasAuthorship W1998733860A5015458167 @default.
- W1998733860 hasAuthorship W1998733860A5030664010 @default.
- W1998733860 hasAuthorship W1998733860A5032374309 @default.
- W1998733860 hasAuthorship W1998733860A5048848299 @default.
- W1998733860 hasAuthorship W1998733860A5051693361 @default.
- W1998733860 hasAuthorship W1998733860A5052633473 @default.
- W1998733860 hasAuthorship W1998733860A5056779273 @default.
- W1998733860 hasAuthorship W1998733860A5074213191 @default.
- W1998733860 hasAuthorship W1998733860A5077161809 @default.
- W1998733860 hasAuthorship W1998733860A5079043712 @default.
- W1998733860 hasBestOaLocation W19987338601 @default.
- W1998733860 hasConcept C126322002 @default.
- W1998733860 hasConcept C142462285 @default.
- W1998733860 hasConcept C187212893 @default.
- W1998733860 hasConcept C203014093 @default.
- W1998733860 hasConcept C207103383 @default.
- W1998733860 hasConcept C2781413609 @default.
- W1998733860 hasConcept C2993143319 @default.
- W1998733860 hasConcept C3013748606 @default.
- W1998733860 hasConcept C44249647 @default.
- W1998733860 hasConcept C71924100 @default.
- W1998733860 hasConceptScore W1998733860C126322002 @default.
- W1998733860 hasConceptScore W1998733860C142462285 @default.
- W1998733860 hasConceptScore W1998733860C187212893 @default.
- W1998733860 hasConceptScore W1998733860C203014093 @default.
- W1998733860 hasConceptScore W1998733860C207103383 @default.
- W1998733860 hasConceptScore W1998733860C2781413609 @default.
- W1998733860 hasConceptScore W1998733860C2993143319 @default.
- W1998733860 hasConceptScore W1998733860C3013748606 @default.
- W1998733860 hasConceptScore W1998733860C44249647 @default.
- W1998733860 hasConceptScore W1998733860C71924100 @default.
- W1998733860 hasIssue "14" @default.
- W1998733860 hasLocation W19987338601 @default.